<DOC>
	<DOCNO>NCT00135668</DOCNO>
	<brief_summary>Sodium nitroprusside ( SNP ) approve control blood pressure adult , yet control study child . The purpose study determine efficacy safety sodium nitroprusside child surgery , require blood pressure lower order decrease amount blood loss surgery .</brief_summary>
	<brief_title>Dose-Response Study Sodium Nitroprusside Children Requiring Controlled Hypotension Operating Room</brief_title>
	<detailed_description>The trial multicenter randomize , double-blind , parallel group , dose-ranging , effect-controlled study examine effect sodium nitroprusside pediatric subject require relative hypotension surgical medical procedure . The goal establish start maximum infusion rate afford optimum blood pressure control child safe dose regimen child . The objective describe relationship infusion rate nitroprusside change blood pressure . The specific aim trial : 1 . To define onset offset blood pressure lower effect nitroprusside obtain adequate instruction dose titration pediatric population . 2 . To construct dose-response model defines relationship nitroprusside infusion rate change blood pressure pediatric subject . 3 . To assess safety nitroprusside administration pediatric subject require control reduction blood pressure .</detailed_description>
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Nitroprusside</mesh_term>
	<criteria>Study subject must meet following criterion : Subject le 17 year age Neonates must fullterm gestation body weight least 2.5 kg Subject require pharmacologicallyinduced hypotension acute blood pressure management surgery invasive procedure , e.g. , cerebral artery embolization Duration subject 's control hypotension expect â‰¥ 2 hour Subject require general anesthesia endotracheal intubation Subject require placement intraarterial line surgical medical procedure The subject 's parent legal guardian give permission ( informed consent ) subject give assent appropriate . Subjects exclude follow criterion exist : Subject know allergy SNP Subject know mitochondrial cytopathy disorder oxidative phosphorylation respiratory chain enzyme Subject contraindication vasodilator therapy control blood pressure surgery procedure Subject participate clinical trial investigational drug and/or device within 30 day prior enrollment Subject serious medical condition , opinion investigator , likely interfere study procedure Subject moribund ( death likely occur within 48 hour ) Subject positive result urine serum human chorionic gonadotropin ( HCG ) test administer screening .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>child</keyword>
	<keyword>sodium nitroprusside</keyword>
	<keyword>control hypotension</keyword>
	<keyword>dose-response</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmacodynamics</keyword>
	<keyword>safety</keyword>
	<keyword>efficacy</keyword>
</DOC>